Navigation Links
European Medicines Agency (EMEA) Recommends Herceptin For Early Stage Breast Cancer

The European Medicines Agency (EMEA) has recommended the use of breast cancer drug Herceptin in early stages of the cancer in a record 27 days review//. A license for the drug is to be issued in three months time.

The National Institute of Health and Clinical Excellence in the UK will decide now if Herceptin can be recommended in the NHS. The drug, which costs £20,000 a year, is already being fast tracked by NICE. "We will be able to issue national guidance to the NHS on the use of Herceptin within weeks of the drug being licensed for safety by the EMEA," said Andrew Dillon, NICE chief executive.

Herceptin is already licensed for use in advanced breast cancer. But some trials showed that it is useful in early stages as well and the UK has seen a number of women drag NHS trusts to court over refusal to fund the drug. Health Secretary Patricia Hewitt had said last October that NHS bodies must not refuse the drug, if the doctors had recommended it.

But NHS trusts continued to refuse the drug, forcing patients to seek refuge in court. Ann Marie Rogers of Swindon, Wiltshire won a case earlier this month ruling forcing her local primary care trust to fund Herceptin. The news of Herceptin's approval by the EMEA was welcomed by charity Breakthrough Breast Cancer, "Not only does this confirm the drug's importance, it should also help reassure those who may have previously doubted its effectiveness and safety," said Chief executive Jeremy Hughes. "We hope that in light of today's decision, any PCT still wavering about prescribing Herceptin, should now have the confidence to make it available to all for whom it is recommended."


'"/>




Page: 1

Related medicine news :

1. Lung Cancer Deaths Declining In Men But Not Women In European Countries
2. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
3. European Countries To Fund $4 Billion For Vaccination For Poor Children’
4. Nanotechnology Revolution To Be Spearheaded By European Union
5. Detection of Weak strains of bird flu virus – Target of European Unio
6. Europe On High Bird Flu Alert: European Commission
7. Slovenia, Bulgaria, Greece Face Bird Flu Threat: European Union
8. Heart Brakes: Hearts in European Union Invite Health Attention
9. European Union: Poultry producers Need Aid to Survive Bird flu crisis
10. 5th European Breast Cancer Conference Talks about Everything from Patient to Oncologist
11. Control And Prevention Of Three Diseases To Be Discussed: European Commission
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical ... recently joined their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, ... excited to add this excellent dermatology practice to our group’s medical services,” explains ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion ... deck space. Since the lift is mounted on wheels, it can be wheeled out of ... down kit, to fasten to the deck. "We have transformed the feedback from customers into ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... ... ... International Protein, a company based out of Australia that focuses on developing ... trade show in Hilton Head, SC. , International Protein was founded by Christine ... of products that would elevate her fitness regime. At this ECRM trade show, Envall ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 20, 2017 ResMed (NYSE: RMD ), BMC ... Winter Haven, Florida ) today announced they have agreed on ... 3B will be permitted to sell their existing products in exchange ... settlement payment to 3B to close the Florida ... an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... 20, 2017  Today, during a plenary ... Pathways in Immunology, Growth Disorders and Cancer," ... INFI ) presented preclinical data for ... selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data showed ... resistance to checkpoint inhibition by remodeling the ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal ... report to their offering. ... The global clinical laboratory testing market is expected ... innovative solutions on the grounds of maximum efficiency and minimum error ...
Breaking Medicine Technology: